Valerie H Curran
Biographic Data
| ID | 7842330 |
|---|---|
| NAME | Valerie H Curran |
| GIVEN NAMES | Valerie H |
| FAMILY NAME | Curran |
| SIGNATURE | CURRAN V H |
| AFFILIATIONS | University College London |
| ORCID | 0000-0001-6041-5214 |
| VERIFIED | Yes |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 11 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1999 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
An Exploration of the Nature and Prevalence of Substance Use in a Forensic Population and an Evaluation of Its Role in Recall to Hospital
Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey…
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use
BACKGROUND: Cannabis use is common, especially among young people, and is associated with risks for various health harms. Some jurisdictions have recently moved to legalization/regulation pursuing public health goals. Evidence-based 'Lower Risk Cannabis Use Guidelines' (LRCUG) and recommendations were previously developed to reduce modifiable risk factors of cannabis-related adverse health outcomes; related evidence has evolved substantially sinc…
Illicit Drug Use and Associated Problems in the Nightlife Scene
Illicit drug use is prevalent in the nightlife scene, especially at electronic dance music (EDM) events. The aim of the present study was to investigate illicit drug use patterns and consequences of drug use among frequent visitors of EDM events. Young adults (18-34 years old) who had visited at least six EDM events in Sweden during the past year participated in a web-based survey on drug use patterns and its consequences. Fifty-nine percent of p…
How do online and offline sampling compare in a multinational study of drug use and nightlife behaviour?”
Psilocybin with psychological support for treatment-resistant depression
RATIONALE: Recent clinical trials are reporting marked improvements in mental health outcomes with psychedelic drug-assisted psychotherapy. OBJECTIVES: Here, we report on safety and efficacy outcomes for up to 6 months in an open-label trial of psilocybin for treatment-resistant depression. METHODS: Twenty patients (six females) with (mostly) severe, unipolar, treatment-resistant major depression received two oral doses of psilocybin (10 and 25 m…
Non-Dependent and Dependent Daily Cannabis Users Differ in Mental Health but Not Prospective Memory Ability
Research suggests that daily cannabis users have impaired memory for past events, but it is not clear whether they are also impaired in prospective memory (PM) for future events. The present study examined PM in daily cannabis users who were either dependent ( n = 18) or non-dependent ( n = 18), and compared them with non-using controls ( n = 18). The effect of future event simulation (FES) on PM performance was also examined. Participants were m…
Psilocybin with psychological support for treatment-resistant depression
BACKGROUND: Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life anxiety, obsessive-compulsive disorder, and smoking and alcohol dependence, with promising preliminary results. Here, we aimed to investigate the feasibility, safety, and efficacy of psilocybin in patients with unipolar treatment-re…
Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach
Background: An international expert panel convened by the Independent Scientific Committee on Drugs developed a multi-criteria decision analysis model of the relative importance of different types of harm related to the use of nicotine-containing products. Method: The group defined 12 products and 14 harm criteria. Seven criteria represented harms to the user, and the other seven indicated harms to others. The group scored all the products on eac…
Investigating the interaction between schizotypy, divergent thinking and cannabis use
Cannabis acutely increases schizotypy and chronic use is associated with elevated rates of psychosis. Creative individuals have higher levels of schizotypy, however links between cannabis use, schizotypy and creativity have not been investigated. We investigated the effects of cannabis smoked naturalistically on schizotypy and divergent thinking, a measure of creativity. One hundred and sixty cannabis users were tested on 1 day when sober and ano…
Dissociative Effects of Alcohol on Recollective Experience
No prominent works on this page.
Dissociative Effects of Alcohol on Recollective Experience
Investigating the interaction between schizotypy, divergent thinking and cannabis use
Cannabis acutely increases schizotypy and chronic use is associated with elevated rates of psychosis. Creative individuals have higher levels of schizotypy, however links between cannabis use, schizotypy and creativity have not been investigated. We investigated the effects of cannabis smoked naturalistically on schizotypy and divergent thinking, a measure of creativity. One hundred and sixty cannabis users were tested on 1 day when sober and ano…
Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach
Background: An international expert panel convened by the Independent Scientific Committee on Drugs developed a multi-criteria decision analysis model of the relative importance of different types of harm related to the use of nicotine-containing products. Method: The group defined 12 products and 14 harm criteria. Seven criteria represented harms to the user, and the other seven indicated harms to others. The group scored all the products on eac…
Psilocybin with psychological support for treatment-resistant depression
BACKGROUND: Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life anxiety, obsessive-compulsive disorder, and smoking and alcohol dependence, with promising preliminary results. Here, we aimed to investigate the feasibility, safety, and efficacy of psilocybin in patients with unipolar treatment-re…
Psilocybin with psychological support for treatment-resistant depression
RATIONALE: Recent clinical trials are reporting marked improvements in mental health outcomes with psychedelic drug-assisted psychotherapy. OBJECTIVES: Here, we report on safety and efficacy outcomes for up to 6 months in an open-label trial of psilocybin for treatment-resistant depression. METHODS: Twenty patients (six females) with (mostly) severe, unipolar, treatment-resistant major depression received two oral doses of psilocybin (10 and 25 m…
Non-Dependent and Dependent Daily Cannabis Users Differ in Mental Health but Not Prospective Memory Ability
Research suggests that daily cannabis users have impaired memory for past events, but it is not clear whether they are also impaired in prospective memory (PM) for future events. The present study examined PM in daily cannabis users who were either dependent ( n = 18) or non-dependent ( n = 18), and compared them with non-using controls ( n = 18). The effect of future event simulation (FES) on PM performance was also examined. Participants were m…
How do online and offline sampling compare in a multinational study of drug use and nightlife behaviour?”
Illicit Drug Use and Associated Problems in the Nightlife Scene
Illicit drug use is prevalent in the nightlife scene, especially at electronic dance music (EDM) events. The aim of the present study was to investigate illicit drug use patterns and consequences of drug use among frequent visitors of EDM events. Young adults (18-34 years old) who had visited at least six EDM events in Sweden during the past year participated in a web-based survey on drug use patterns and its consequences. Fifty-nine percent of p…
An Exploration of the Nature and Prevalence of Substance Use in a Forensic Population and an Evaluation of Its Role in Recall to Hospital
Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey…
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use
BACKGROUND: Cannabis use is common, especially among young people, and is associated with risks for various health harms. Some jurisdictions have recently moved to legalization/regulation pursuing public health goals. Evidence-based 'Lower Risk Cannabis Use Guidelines' (LRCUG) and recommendations were previously developed to reduce modifiable risk factors of cannabis-related adverse health outcomes; related evidence has evolved substantially sinc…
Psychiatry (10 works) · Psychology (10 works) · Medicine (9 works) · Cannabis (6 works) · Clinical Psychology (6 works) · Anxiety (4 works) · Environmental health (4 works) · Clinical Psychology (3 works) · Cognition (3 works) · Forensic Toxicology and Drug Analysis (3 works)